Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pain 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Agnosia 2Thyroid Nodule 1Prostatic Neoplasms 1Neuroma 1Neuralgia 1Neoplasm Metastasis 1Myoma 1Multiple Pulmonary Nodules 1Multiple Advanced Tumors After PD-1 Therapy Failure 1Menorrhagia 1Lymphoma, Follicular 1Lipoma 1Leiomyoma 1Hypesthesia 1Hyperthyroidism 1Hyperaldosteronism 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cicatrix 1Carcinoma, Renal Cell 1Breast Cancer Female 1Bone Cancer Metastatic 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1ACTH Syndrome, Ectopic 1

Interventions

Bevacizumab 67atezolizumab 53durvalumab 43lenvatinib 42Nivolumab 37pembrolizumab 35tremelimumab 29Magnetic Resonance Spectroscopy 21Specimen Handling 19tislelizumab 18sintilimab 16Ipilimumab 15Sorafenib 14regorafenib 13Radiosurgery 13cabozantinib 12Radiotherapy 12apatinib 10Immunoglobulin G 10Blood Specimen Collection 10Immune Checkpoint Inhibitors 9Disulfides 9camrelizumab 8X-Rays 8Cyclophosphamide 8Oxaliplatin 7Immunotherapy 7Folfox protocol 7Fluorouracil 7donafenib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Radiofrequency Ablation × 1 year × Clear all
NCT05666271 2026-04-13

Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes

Seoul National University Hospital

Active not recruiting
76 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03753659 2026-03-23

IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed
30 enrolled 10 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡